Advertisement
Home 2015

Archives

Counterfeit Botox may have been distributed to doctors' offices and medical clinics across the United States

FDA: Counterfeit Botox Found in the United States

0
Agency recommends physicians closely examine Botox packaging
Experts are predicting that this allergy season may be one of the worst in years.

Allergy Season Predicted to Be One of the Worst, but Shorter

0
Doctors predict a shorter but rougher stretch of coughing, sneezing, and wheezing
Nearly one in 10 full-time workers in the United States have had a recent substance abuse problem

Recent Substance Abuse Found in Nearly One in 10 Workers

0
Government report detects uptick among hotel, food service employees
A potent new designer drug called "flakka" is making headlines across the United States

Synthetic Drug ‘Flakka’ Causes Hallucinations, Fits of Rage

0
Use of chemical-cousin to 'bath salts' appears to be on the rise, experts say
Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure

FDA Approves Corlanor for Chronic Heart Failure

0
Works by decreasing heart rate; first approved product in this drug class
Recently adopted legislation has repealed the sustainable growth rate formula

AMA Announces End of Sustainable Growth Rate Formula

0
Legislation includes provisions such as simplification of reporting programs, incentive payments
A clinical trial of an Ebola vaccine has been launched in the West African nation of Sierra Leone

CDC: Ebola Vaccine Trial Launches in Sierra Leone

0
Roughly 6,000 health workers will get shots in country hit hard by current outbreak
Significantly more adults in Florida and Texas struggle to pay medical bills or pay off medical debt over time compared with residents of New York and California

Medical Debt Burden Higher in Texas, Florida

0
California and New York fully expanded Medicaid coverage under ACA, but Texas and Florida did not
Nearly all pharmacists have experienced upswings in the acquisition costs of generic drugs

Pharmacists Raise Concerns for Patient Access to Generic Drugs

0
Survey shows it takes one month or longer for PBMs to fix maximum allowed costs underpayments
Physicians have only 45 days to review and dispute reports regarding their financial ties to drug and medical device manufacturers reported under the Physician Payments Sunshine Act

Limited Time Available to Review Sunshine Act Data

0
Doctors have limited time period to review financial data and dispute reports before they go public